P

Protagonist Therapeutics
D

PTGX

49.920
USD
-1.10
(-2.15%)
مفتوح الان
حجم التداول
32,737
الربح لكل سهم
-0
العائد الربحي
-
P/E
64
حجم السوق
3,093,519,374
أصول ذات صلة
B
BEAM
-0.650
(-3.26%)
19.300 USD
C
CRSP
-1.250
(-2.40%)
50.870 USD
E
EDIT
-0.05000
(-1.95%)
2.52000 USD
GILD
GILD
0.280
(0.25%)
111.040 USD
MRNA
MRNA
-0.350
(-1.15%)
30.130 USD
N
NTLA
-0.330
(-3.08%)
10.380 USD
VRTX
VRTX
-0.49
(-0.11%)
459.29 USD
المزيد
الأخبار المقالات

العنوان: Protagonist Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Itspipeline products include Rusfertide (PTG-300) and JNJ-2113.